2019
Inflammatory bowel disease incidence in South Moravian Region (Czech Republic); 2002-2016
JABANDŽIEV, Petr, Tereza PINKASOVÁ, Jan PAPEŽ, Martin JOUZA, Kateřina BAJEROVÁ et. al.Základní údaje
Originální název
Inflammatory bowel disease incidence in South Moravian Region (Czech Republic); 2002-2016
Autoři
JABANDŽIEV, Petr (203 Česká republika, garant, domácí), Tereza PINKASOVÁ (203 Česká republika, domácí), Jan PAPEŽ (203 Česká republika, domácí), Martin JOUZA (203 Česká republika, domácí), Kateřina BAJEROVÁ (203 Česká republika, domácí), Bára KARLÍNOVÁ (203 Česká republika, domácí), Júlia KOVÁČOVÁ (703 Slovensko), Ondřej SLABÝ (203 Česká republika, domácí) a Milan BAJER (203 Česká republika, domácí)
Vydání
Crohn's and Colitis Congress, 2019
Další údaje
Jazyk
angličtina
Typ výsledku
Konferenční abstrakt
Obor
30209 Paediatrics
Stát vydavatele
Nizozemské království
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 17.373
Kód RIV
RIV/00216224:14110/19:00111079
Organizační jednotka
Lékařská fakulta
ISSN
UT WoS
000458180600101
Klíčová slova česky
zánětlivá střevní onemocnění; děti; jižní Morava
Klíčová slova anglicky
inflammatory bowel disease; children; South Moravian Region
Štítky
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 16. 4. 2020 08:21, Mgr. Tereza Miškechová
Anotace
V originále
Inflammatory bowel disease is considered a global disease in the 21st century. Studies worldwide have shown an increase in incidence in paediatric population. The aim of the study was to detect the rising incidence of IBD in paediatric population (approximately 240 000) over a 15-year period in the South Moravian Region of the Czech Republic. Another objective was to characterize differences by sex, age and to determine the future projection of incidence of IBD in the region and, by extension, the whole Czech Republic. Methods In the Czech Republic, the treatment of paediatric IBD is centralized into hospitals that provide tertiary care. University Hospital of Brno is one of the gastroenterology centres that provides a complex treatment of IBD patients. We evaluated 321 consecutive paediatric IBD patients < 19 years of age in the South Moravian region (one of the 14 regional units in the Czech Republic). They all had been diagnosed according to the relevant guidelines. Results We evaluated 321 patiens with IBD: 167 of them had Crohn’s disease (52.0%), 114 had ulcerative colitis (35.5%) and 40 were IBD-unclassified (12.5%). Among all the cases of IBD, 53.8% were males. The average age of a diagnosed person was 13.37 years (95%CI: 12.97-13.76) and the patients went an average of 7.59 months (95%CI: 6.15-9.03) between the first symptoms and the diagnosis. The overall incidence of IBD significantly increased from 2.84 per 100 000 person-years in 2002 to 12.54 per 100 000 person-years in 2016 (P = 0.012). Conclusions Our results show that the overal incidence of paediatric IBD is increasing. These data highlight the need for a further research to identify the possible risk factors of IBD development This work was supported by the Ministry of Health of the Czech Republic, grant nr. 16-31314A, 16-31765A and RVO (FnBr, 65269705).